Cristin Hubbard - May 20, 2024 Form 4 Insider Report for BIOMARIN PHARMACEUTICAL INC (BMRN)

Role
EVP, Chief Commercial Officer
Signature
/s/ Tae Sang Yoo, Attorney-in-Fact
Stock symbol
BMRN
Transactions as of
May 20, 2024
Transactions value $
$0
Form type
4
Date filed
5/22/2024, 04:36 PM

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction BMRN Common Stock Award $0 +14.7K $0.00 14.7K May 20, 2024 Direct F1
transaction BMRN Common Stock Award $0 +4.7K +31.99% $0.00 19.4K May 20, 2024 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction BMRN Stock Option (Right to Buy Common Stock) Award $0 +33.5K $0.00 33.5K May 20, 2024 Common Stock 33.5K $77.05 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Restricted stock units granted on May 20, 2024. Price not applicable.
F2 Option grant vests 12/48th on May 20, 2025 and 1/48th on the 1st day of each month thereafter.